FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2074367353> ?p ?o ?g. }

• W2074367353 abstract "Proceedings: AACR 101st Annual Meeting 2010‐‐ Apr 17‐21, 2010; Washington, DCNatural products have received increasing attention in recent years for the discovery of novel cancer preventive and therapeutic agents. The root of Panax ginseng has been used for thousands of years in Korean medicine practice for treatment of diverse ailments. More recent studies have indicated that ginsenoside saponins, a constituents of Panax ginseng can induce retardation of growth and cell death of cancer in culture and in vivo. In this study, we used two human breast cancer cells, MCF7 (wild type p53, ER responsive), MDA-MB-231 (mutated p53, ER-independent) and xenograft nude mouse model to investigate further insights into the mechanism of Ginsenoside Rh2-induced cell death. It was observed that Rh2 treatment significantly decreases viability at 40 to 60 μM concentrations as judged by trypan blue dye exclusion assay in both two cell lines. Rh2 treatment also increased in a concentration- and time-dependent cell death in cytoplasmic histone-associated DNA fragmentation assay. Bcl-2 family proteins have emerged as critical regulators of apoptosis by functioning either as promoters (e.g., Bax and Bak) or inhibitors (e.g., Bcl-2 and Bcl-xL) of the cell death process. Rh2-induced apoptosis was correlated with induction of Bax and Bak and a decrease in Bcl-xL and Bcl-2 protein levels in both two cell lines. Transient transfection of MCF7 cells with Bak- and Bax-targeted siRNAs conferred partial yet significant protection against ginsenoside Rh2-induced apoptosis. The increased expression level of Bax was associated with initiation of intrinsic apoptotic pathway. The pathway initiated translocation of Bax from cytosol following release of mitochondrial cytochrome c dependent on ginsenoside Rh2 treatment time. To test whether Rh2-mediated inhibition of MDA-MB-231 xenograft growth in vivo at the 2mg dose was due to increased apoptosis, tumor tissues from control and Rh2-treated mice were examined for histologic evidence of apoptosis. The tumors from Rh2-treated mice exhibited markedly higher count of apoptotic bodies and reduced proliferation index. The tumor section also exhibited the changed protein level compared with control one in specific for Bax or Bcl-2 immunohistochemistry. It was consistent in RT-PCR using appropriate Bcl2- family gene primers. In conclusion, our data suggests Rh2-mediated suppression of MDA-MB-231 xenograft growth in vivo and MF7 cells in vitro highly correlates with increased apoptosis. The results of the present study show that the ability of Rh2 to inhibit cell growth or cause apoptotic cell death in two human breast cancer cells is not influenced by either p53 functional status or ER responsiveness.Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 218." @default.
• W2074367353 created "2016-06-24" @default.
• W2074367353 creator A5006602557 @default.
• W2074367353 creator A5016519294 @default.
• W2074367353 creator A5021061898 @default.
• W2074367353 creator A5050803830 @default.
• W2074367353 date "2010-04-15" @default.
• W2074367353 modified "2023-09-26" @default.
• W2074367353 title "Abstract 218: Ginsenoside Rh2 induced bcl2 family proteins mediated apoptosis in vitro and xenograft in vivo" @default.
• W2074367353 doi "https://doi.org/10.1158/1538-7445.am10-218" @default.
• W2074367353 hasPublicationYear "2010" @default.
• W2074367353 type Work @default.
• W2074367353 sameAs 2074367353 @default.
• W2074367353 citedByCount "0" @default.
• W2074367353 crossrefType "proceedings-article" @default.
• W2074367353 hasAuthorship W2074367353A5006602557 @default.
• W2074367353 hasAuthorship W2074367353A5016519294 @default.
• W2074367353 hasAuthorship W2074367353A5021061898 @default.
• W2074367353 hasAuthorship W2074367353A5050803830 @default.
• W2074367353 hasConcept C121608353 @default.
• W2074367353 hasConcept C126322002 @default.
• W2074367353 hasConcept C142724271 @default.
• W2074367353 hasConcept C153911025 @default.
• W2074367353 hasConcept C185592680 @default.
• W2074367353 hasConcept C190283241 @default.
• W2074367353 hasConcept C204787440 @default.
• W2074367353 hasConcept C207001950 @default.
• W2074367353 hasConcept C2779232237 @default.
• W2074367353 hasConcept C2780070996 @default.
• W2074367353 hasConcept C31573885 @default.
• W2074367353 hasConcept C43759708 @default.
• W2074367353 hasConcept C502942594 @default.
• W2074367353 hasConcept C53227056 @default.
• W2074367353 hasConcept C54355233 @default.
• W2074367353 hasConcept C55493867 @default.
• W2074367353 hasConcept C71924100 @default.
• W2074367353 hasConcept C81885089 @default.
• W2074367353 hasConcept C86803240 @default.
• W2074367353 hasConcept C98274493 @default.
• W2074367353 hasConceptScore W2074367353C121608353 @default.
• W2074367353 hasConceptScore W2074367353C126322002 @default.
• W2074367353 hasConceptScore W2074367353C142724271 @default.
• W2074367353 hasConceptScore W2074367353C153911025 @default.
• W2074367353 hasConceptScore W2074367353C185592680 @default.
• W2074367353 hasConceptScore W2074367353C190283241 @default.
• W2074367353 hasConceptScore W2074367353C204787440 @default.
• W2074367353 hasConceptScore W2074367353C207001950 @default.
• W2074367353 hasConceptScore W2074367353C2779232237 @default.
• W2074367353 hasConceptScore W2074367353C2780070996 @default.
• W2074367353 hasConceptScore W2074367353C31573885 @default.
• W2074367353 hasConceptScore W2074367353C43759708 @default.
• W2074367353 hasConceptScore W2074367353C502942594 @default.
• W2074367353 hasConceptScore W2074367353C53227056 @default.
• W2074367353 hasConceptScore W2074367353C54355233 @default.
• W2074367353 hasConceptScore W2074367353C55493867 @default.
• W2074367353 hasConceptScore W2074367353C71924100 @default.
• W2074367353 hasConceptScore W2074367353C81885089 @default.
• W2074367353 hasConceptScore W2074367353C86803240 @default.
• W2074367353 hasConceptScore W2074367353C98274493 @default.
• W2074367353 hasLocation W20743673531 @default.
• W2074367353 hasOpenAccess W2074367353 @default.
• W2074367353 hasPrimaryLocation W20743673531 @default.
• W2074367353 hasRelatedWork W1967644138 @default.
• W2074367353 hasRelatedWork W1976859333 @default.
• W2074367353 hasRelatedWork W1997174688 @default.
• W2074367353 hasRelatedWork W1999341523 @default.
• W2074367353 hasRelatedWork W2006041644 @default.
• W2074367353 hasRelatedWork W2069439192 @default.
• W2074367353 hasRelatedWork W2102531624 @default.
• W2074367353 hasRelatedWork W2107644586 @default.
• W2074367353 hasRelatedWork W2164544843 @default.
• W2074367353 hasRelatedWork W2270951111 @default.
• W2074367353 hasRelatedWork W2296516207 @default.
• W2074367353 hasRelatedWork W2390795618 @default.
• W2074367353 hasRelatedWork W2413488134 @default.
• W2074367353 hasRelatedWork W2799610320 @default.
• W2074367353 hasRelatedWork W2956120516 @default.
• W2074367353 hasRelatedWork W2977558826 @default.
• W2074367353 hasRelatedWork W3029906927 @default.
• W2074367353 hasRelatedWork W3115208379 @default.
• W2074367353 hasRelatedWork W3139394554 @default.
• W2074367353 hasRelatedWork W1924893992 @default.
• W2074367353 isParatext "false" @default.
• W2074367353 isRetracted "false" @default.
• W2074367353 magId "2074367353" @default.
• W2074367353 workType "article" @default.